CVS Health (CVS – Research Report) received a Buy rating and an $82.00 price target from Barclays analyst Andrew Mok CFA today. The ...

CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in ...

CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...

On the heels of its recent announcement that CVS Health will eliminate about 2,900 jobs nationwide, the health care giant is ...

Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health ...

CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m. ET to discuss third quarter 2024 financial results.

This post was written by Melanie Riehl CVS Health Corporation ( NYSE:CVS ) shareholders should be happy to see the share price up 17% in the last month. But... Aetna®, a CVS Health® company ...

Barclays analyst Andrew Mok CFA maintained a Hold rating on CVS Health (CVS – Research Report) today and set a price target of $63.00.

Shares of CVS Health Corp. CVS shed 0.33% to $66.63 Friday, on what proved to be an all-around great trading session for the ...

CVS Health announced that it will cut 2,900 jobs as part of a cost-cutting plan. The layoffs will mostly affect corporate ...

It’s time for a wellness check at CVS Health. Shares of the company are down more than 20% this year as it grapples with higher-than-expected medical costs in its insurance unit and pharmacy ...

CVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the ...